Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe F Rodrigues

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Inflammopharmacology|November 27, 2019
Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanismsFelipe F Rodrigues, Marcela I Morais, Ivo S F Melo, et al.
European Journal of Pharmacology|June 26, 2019
Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanismsPaulo S A Augusto, Alysson V Braga, Felipe F Rodrigues, et al.
Cytokine|December 15, 2023
Metformin inhibits paclitaxel-induced mechanical allodynia by activating opioidergic pathways and reducing cytokines production in the dorsal root ganglia and thalamusMarcela Í Morais, Alysson V Braga, Roger R L Silva, et al.
European Journal of Pharmacology|October 19, 2017
Antiallodynic activity of leflunomide is partially inhibited by naltrexone and glibenclamide and associated with reduced production of TNF-α and CXCL-1Ana Mercy S Brito, Adriana M Godin, Paulo Sérgio A Augusto, et al.
Inflammopharmacology|December 1, 2021
Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α productionPaulo S A Augusto, Tamires C Matsui, Alysson V Braga, et al.
European Journal of Pharmacology|May 28, 2019
4-Methylbenzenecarbothioamide, a hydrogen sulfide donor, inhibits tumor necrosis factor-α and CXCL1 production and exhibits activity in models of pain and inflammationIvo S F Melo, Felipe F Rodrigues, Sarah O A M Costa, et al.
Inflammopharmacology|January 30, 2022
RI75, a curcumin analogue, inhibits tumor necrosis factor-α and interleukin-6 production and exhibits antiallodynic and antiedematogenic activities in miceSarah O A M Costa, Ianny B Rodrigues, Alysson V Braga, et al.
Pharmacological Reports : PR|August 23, 2024
Nicorandil antiallodynic activity in a model of neuropathic pain is associated with the activation of ATP-dependent potassium channels and opioidergic pathways, and reduced production of cytokines and neutrophils recruitment in paw, sciatic nerve, and dorsal root gangliaAlysson V Braga, Marcela Í Morais, Darly G S Delfino, et al.
International Immunopharmacology|July 10, 2023
A clindamycin acetylated derivative with reduced antibacterial activity inhibits articular hyperalgesia and edema by attenuating neutrophil recruitment, NF-κB activation and tumor necrosis factor-α productionFelipe F Rodrigues, Cleudiomar I Lino, Vívian L S Oliveira, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Inflammopharmacology|November 27, 2019
Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanismsFelipe F Rodrigues, Marcela I Morais, Ivo S F Melo, et al.
European Journal of Pharmacology|June 26, 2019
Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanismsPaulo S A Augusto, Alysson V Braga, Felipe F Rodrigues, et al.
Cytokine|December 15, 2023
Metformin inhibits paclitaxel-induced mechanical allodynia by activating opioidergic pathways and reducing cytokines production in the dorsal root ganglia and thalamusMarcela Í Morais, Alysson V Braga, Roger R L Silva, et al.
European Journal of Pharmacology|October 19, 2017
Antiallodynic activity of leflunomide is partially inhibited by naltrexone and glibenclamide and associated with reduced production of TNF-α and CXCL-1Ana Mercy S Brito, Adriana M Godin, Paulo Sérgio A Augusto, et al.
Inflammopharmacology|December 1, 2021
Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-α productionPaulo S A Augusto, Tamires C Matsui, Alysson V Braga, et al.
European Journal of Pharmacology|May 28, 2019
4-Methylbenzenecarbothioamide, a hydrogen sulfide donor, inhibits tumor necrosis factor-α and CXCL1 production and exhibits activity in models of pain and inflammationIvo S F Melo, Felipe F Rodrigues, Sarah O A M Costa, et al.
Inflammopharmacology|January 30, 2022
RI75, a curcumin analogue, inhibits tumor necrosis factor-α and interleukin-6 production and exhibits antiallodynic and antiedematogenic activities in miceSarah O A M Costa, Ianny B Rodrigues, Alysson V Braga, et al.
Pharmacological Reports : PR|August 23, 2024
Nicorandil antiallodynic activity in a model of neuropathic pain is associated with the activation of ATP-dependent potassium channels and opioidergic pathways, and reduced production of cytokines and neutrophils recruitment in paw, sciatic nerve, and dorsal root gangliaAlysson V Braga, Marcela Í Morais, Darly G S Delfino, et al.
International Immunopharmacology|July 10, 2023
A clindamycin acetylated derivative with reduced antibacterial activity inhibits articular hyperalgesia and edema by attenuating neutrophil recruitment, NF-κB activation and tumor necrosis factor-α productionFelipe F Rodrigues, Cleudiomar I Lino, Vívian L S Oliveira, et al.
Pageof 2